Dr. Jaap Laufer - Vice President, Public Affairs

Jaap Laufer MD, PharmD, has 25+ years of experience in Regulatory and Medical Affairs at major pharmaceutical and technology-intensive medical device companies. He serves as Senior Regulatory Counsel to the Management or Board of several major medical device manufacturers, but also of venture capital funded companies.

In addition to working with Emergo Group, Dr. Laufer manages his own regulatory consulting firm serving medical device and IVD clients worldwide. He was also VP of Regulatory and Clinical Affairs for LipoMatrix, Inc. in Neuchatel, Switzerland. When Collagen Corp. of Palo Alto, CA, acquired LipoMatrix, he became their Vice President of Regulatory Affairs. Before he joined LipoMatrix, Dr. Laufer held a number of managerial positions of increasing responsibility within Pfizer. In this capacity he was responsible for regulatory approval and compliance and medical matters concerning a wide variety of active and non-active medical devices.

On top of being an experienced auditor for compliance with ISO (accredited with ZLG) and FDA Quality System Regulations, Dr. Laufer managed many clinical studies, sometimes from inception to publication. He is a regular contributor and past Chairman of Regulatory Affairs Professional Society (RAPS), Europe (1993-1996) and a visiting teacher to the School of Pharmacy at the University of Southern California (USC).